Literature DB >> 26976637

p38β Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues Thr241 and Ser261.

Jonah Beenstock1, Dganit Melamed2, Navit Mooshayef3, Dafna Mordechay1, Benjamin P Garfinkel1, Natalie G Ahn4, Arie Admon2, David Engelberg5.   

Abstract

Many enzymes are self-regulated and can either inhibit or enhance their own catalytic activity. Enzymes that do both are extremely rare. Many protein kinases autoactivate by autophosphorylating specific sites at their activation loop and are inactivated by phosphatases. Although mitogen-activated protein kinases (MAPKs) are usually activated by dual phosphorylation catalyzed by MAPK kinases (MAPKKs), the MAPK p38β is exceptional and is capable of self-activation by cis autophosphorylation of its activation loop residue T180. We discovered that p38β also autophosphorylates in trans two previously unknown sites residing within a MAPK-specific structural element known as the MAPK insert: T241 and S261. Whereas phosphorylation of T180 evokes catalytic activity, phosphorylation of S261 reduces the activity of T180-phosphorylated p38β, and phosphorylation of T241 reduces its autophosphorylation in trans Both phosphorylations do not affect the activity of dually phosphorylated p38β. T241 of p38β is found phosphorylated in vivo in bone and muscle tissues. In myogenic cell lines, phosphorylation of p38β residue T241 is correlated with differentiation to myotubes. T241 and S261 are also autophosphorylated in intrinsically active variants of p38α, but in this protein, they probably play a different role. We conclude that p38β is an unusual enzyme that automodulates its basal, MAPKK-independent activity by several autophosphorylation events, which enhance and suppress its catalytic activity.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26976637      PMCID: PMC4859693          DOI: 10.1128/MCB.01105-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Phosphorylation of Tyr-176 of the yeast MAPK Hog1/p38 is not vital for Hog1 biological activity.

Authors:  Michal Bell; David Engelberg
Journal:  J Biol Chem       Date:  2003-03-10       Impact factor: 5.157

Review 3.  Signal transduction through MAP kinase cascades.

Authors:  T S Lewis; P S Shapiro; N G Ahn
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

4.  A myogenic cell line with altered serum requirements for differentiation.

Authors:  D Yaffe; O Saxel
Journal:  Differentiation       Date:  1977       Impact factor: 3.880

Review 5.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

6.  Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases.

Authors:  Jesus M Salvador; Paul R Mittelstadt; Tad Guszczynski; Terry D Copeland; Hiroshi Yamaguchi; Ettore Appella; Albert J Fornace; Jonathan D Ashwell
Journal:  Nat Immunol       Date:  2005-02-27       Impact factor: 25.606

7.  Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha.

Authors:  Yuan-Yuan Zhang; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

8.  Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription.

Authors:  Nadav Askari; Ron Diskin; Michal Avitzour; Ricardo Capone; Oded Livnah; David Engelberg
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

Review 9.  Stress-activated protein kinases-tumor suppressors or tumor initiators?

Authors:  David Engelberg
Journal:  Semin Cancer Biol       Date:  2004-08       Impact factor: 15.707

10.  Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.

Authors:  Grzegorz Sumara; Ivan Formentini; Stephan Collins; Izabela Sumara; Renata Windak; Bernd Bodenmiller; Reshma Ramracheya; Dorothée Caille; Huiping Jiang; Kenneth A Platt; Paolo Meda; Rudolf Aebersold; Patrik Rorsman; Romeo Ricci
Journal:  Cell       Date:  2009-01-08       Impact factor: 41.582

View more
  6 in total

1.  Active p38α causes macrovesicular fatty liver in mice.

Authors:  Ilona Darlyuk-Saadon; Chen Bai; Chew Kiat Matthew Heng; Nechama Gilad; Wei-Ping Yu; Pei Yen Lim; Amaury Cazenave-Gassiot; Yongliang Zhang; W S Fred Wong; David Engelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

2.  Autophosphorylation Mechanism of the Ser/Thr Kinase Stk1 From Staphylococcus aureus.

Authors:  Weihao Zheng; Xiaodan Cai; Shuiming Li; Zigang Li
Journal:  Front Microbiol       Date:  2018-04-20       Impact factor: 5.640

3.  Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.

Authors:  A Harrison Brody; Sarah Helena Nies; Fulin Guan; Levi M Smith; Bandhan Mukherjee; Santiago A Salazar; Suho Lee; Tu Kiet T Lam; Stephen M Strittmatter
Journal:  Mol Neurodegener       Date:  2022-05-03       Impact factor: 18.879

4.  Estrogen Protects the Female Heart from Ischemia/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38β at Threonine 79 and Serine 106.

Authors:  Tao Luo; Han Liu; Jin Kyung Kim
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 5.  p38β and Cancer: The Beginning of the Road.

Authors:  Olga Roche; Diego M Fernández-Aroca; Elena Arconada-Luque; Natalia García-Flores; Liliana F Mellor; María José Ruiz-Hidalgo; Ricardo Sánchez-Prieto
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

Review 6.  p38β - MAPK11 and its role in female cancers.

Authors:  Periklis Katopodis; Rachel Kerslake; Athanasios Zikopoulos; Nefeli Beri; Vladimir Anikin
Journal:  J Ovarian Res       Date:  2021-06-26       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.